Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
Summary
GlobalData's Medical Devices sector report, “Synthetic Bone Graft Substitutes Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Synthetic Bone Graft Substitutes pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Synthetic bone graft substitutes are used as substitutes to autograft and allograft bone.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Synthetic Bone Graft Substitutes under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Synthetic Bone Graft Substitutes and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Synthetic Bone Graft Substitutes under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Synthetic Bone Graft Substitutes Overview
3 Products under Development
3.1 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
3.2 Synthetic Bone Graft Substitutes - Pipeline Products by Territory
3.3 Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
3.4 Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
3.5 Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
4 Synthetic Bone Graft Substitutes - Pipeline Products under Development by Companies
4.1 Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
4.2 Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
5 Synthetic Bone Graft Substitutes Companies and Product Overview
6 Synthetic Bone Graft Substitutes- Recent Developments
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
List of Tables
Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
Synthetic Bone Graft Substitutes - Pipeline Products by Territory
Synthetic Bone Graft Substitutes - Pipeline Products by Regulatory Path
Synthetic Bone Graft Substitutes - Pipeline Products by Estimated Approval Date
Synthetic Bone Graft Substitutes - Ongoing Clinical Trials
Synthetic Bone Graft Substitutes Companies - Pipeline Products by Stage of Development
Synthetic Bone Graft Substitutes - Pipeline Products by Stage of Development
OIF - Non-Union Bone Fracture - Product Description
OIF/ß-TCP - Block Form - Product Status
OIF/ß-TCP - Block Form - Product Description
OIF/ß-TCP - Granular Form - Product Status
OIF/ß-TCP - Granular Form - Product Description
BioGend Therapeutics Co Ltd - Ongoing Clinical Trials Overview
OIF/ß-TCP - Granular Form - A Randomized, Evaluator-blinded, Controlled Study to Evaluate the Safety and Clinical Performance of OIF/ß-TCP in Patients with Open Tibial Fractures in Need of Bone Grafting
Biomatlante SA Pipeline Products & Ongoing Clinical Trials Overview
Osteoconductive Resorbable Composite - Product Status
S53P4 BonAlive Granules - Effectiveness of Two Bone Substitutes, Natural and Synthetic, in Preserving the Alveolar Ridge of Single-rooted Teeth: a Pilot Single-blind, Parallel Randomised Controlled Trial
S53P4 BonAlive Granules - Short- and Medium-term Evaluation of Mastoid Filling Using Bioactive Glass
Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview
Osteocrete - Bone Anchor - Product Status
Osteocrete - Bone Anchor - Product Description
OsteoCrete - Cranial - Product Status
OsteoCrete - Cranial - Product Description
OsteoCrete - Maxillofacial - Product Status
OsteoCrete - Maxillofacial - Product Description
OsteoCrete - Non Load Bearing Spine - Product Status
OsteoCrete - Non Load Bearing Spine - Product Description
BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Solid Bone Block - Product Status
Solid Bone Block - Product Description
BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview
Cerament + Bisphosphonate - Product Status
Cerament + Bisphosphonate - Product Description
Cerament|G - Product Status
Cerament|G - Product Description
Gelatin/Cerament - Product Status
Gelatin/Cerament - Product Description
BoneSupport AB - Ongoing Clinical Trials Overview
Cerament|G - A Post-Market Prospective Cohort Study on Subjects Receiving CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure
Cerament|G - CERAMENT G Device Registry
Cerament|G - Evaluation of the Efficiency of the Bone Substitute Cerament-G Locally Delivering Gentamicin in the Treatment of Chronic Osteomyelitis of Long Bones: Randomized Multicentre Study in the CRIOAc Network - CONVICTION Study
Cerament|G - Two-stage Treatment of Large Bone Defects with Cerament G and Cerament V plus Auto and/or Allograft Using the Masquelet Technique as Salvage Therapy after Bone Resection in Patients with Septic Pseudarthrosis
Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview